These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Optimization of Prime-Boost Vaccination Strategies Against Mouse-Adapted Ebolavirus in a Short-Term Protection Study. Aviles J; Bello A; Wong G; Fausther-Bovendo H; Qiu X; Kobinger G J Infect Dis; 2015 Oct; 212 Suppl 2():S389-97. PubMed ID: 26038398 [TBL] [Abstract][Full Text] [Related]
8. Structures of protective antibodies reveal sites of vulnerability on Ebola virus. Murin CD; Fusco ML; Bornholdt ZA; Qiu X; Olinger GG; Zeitlin L; Kobinger GP; Ward AB; Saphire EO Proc Natl Acad Sci U S A; 2014 Dec; 111(48):17182-7. PubMed ID: 25404321 [TBL] [Abstract][Full Text] [Related]
9. Production of Recombinant Adeno-associated Virus Vectors Using Suspension HEK293 Cells and Continuous Harvest of Vector From the Culture Media for GMP FIX and FLT1 Clinical Vector. Grieger JC; Soltys SM; Samulski RJ Mol Ther; 2016 Feb; 24(2):287-297. PubMed ID: 26437810 [TBL] [Abstract][Full Text] [Related]
10. Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan Viruses. Holtsberg FW; Shulenin S; Vu H; Howell KA; Patel SJ; Gunn B; Karim M; Lai JR; Frei JC; Nyakatura EK; Zeitlin L; Douglas R; Fusco ML; Froude JW; Saphire EO; Herbert AS; Wirchnianski AS; Lear-Rooney CM; Alter G; Dye JM; Glass PJ; Warfield KL; Aman MJ J Virol; 2016 Jan; 90(1):266-78. PubMed ID: 26468533 [TBL] [Abstract][Full Text] [Related]
11. Sodium Chloride Enhances Recombinant Adeno-Associated Virus Production in a Serum-Free Suspension Manufacturing Platform Using the Herpes Simplex Virus System. Adamson-Small L; Potter M; Byrne BJ; Clément N Hum Gene Ther Methods; 2017 Feb; 28(1):1-14. PubMed ID: 28117600 [TBL] [Abstract][Full Text] [Related]
12. A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection. ; ; Davey RT; Dodd L; Proschan MA; Neaton J; Neuhaus Nordwall J; Koopmeiners JS; Beigel J; Tierney J; Lane HC; Fauci AS; Massaquoi MBF; Sahr F; Malvy D N Engl J Med; 2016 Oct; 375(15):1448-1456. PubMed ID: 27732819 [TBL] [Abstract][Full Text] [Related]
13. Insect cells as a factory to produce adeno-associated virus type 2 vectors. Urabe M; Ding C; Kotin RM Hum Gene Ther; 2002 Nov; 13(16):1935-43. PubMed ID: 12427305 [TBL] [Abstract][Full Text] [Related]
14. Delivering Transgenic DNA Exceeding the Carrying Capacity of AAV Vectors. Hirsch ML; Wolf SJ; Samulski RJ Methods Mol Biol; 2016; 1382():21-39. PubMed ID: 26611576 [TBL] [Abstract][Full Text] [Related]
15. Recombinant adeno-associated virus vector: Is it ideal for gene delivery in liver transplantation? Yang ZF; Wu XB; Tsui TY; Hou YD; Luk JM; Fan ST Liver Transpl; 2003 Apr; 9(4):411-20. PubMed ID: 12682895 [TBL] [Abstract][Full Text] [Related]
16. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Qiu X; Wong G; Audet J; Bello A; Fernando L; Alimonti JB; Fausther-Bovendo H; Wei H; Aviles J; Hiatt E; Johnson A; Morton J; Swope K; Bohorov O; Bohorova N; Goodman C; Kim D; Pauly MH; Velasco J; Pettitt J; Olinger GG; Whaley K; Xu B; Strong JE; Zeitlin L; Kobinger GP Nature; 2014 Oct; 514(7520):47-53. PubMed ID: 25171469 [TBL] [Abstract][Full Text] [Related]
17. Delivery of single-chain antibodies (scFvs) directed against the 37/67 kDa laminin receptor into mice via recombinant adeno-associated viral vectors for prion disease gene therapy. Zuber C; Mitteregger G; Schuhmann N; Rey C; Knackmuss S; Rupprecht W; Reusch U; Pace C; Little M; Kretzschmar HA; Hallek M; Büning H; Weiss S J Gen Virol; 2008 Aug; 89(Pt 8):2055-2061. PubMed ID: 18632978 [TBL] [Abstract][Full Text] [Related]
18. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins. Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907 [No Abstract] [Full Text] [Related]
19. Lack of germline transmission of vector sequences following systemic administration of recombinant AAV-2 vector in males. Arruda VR; Fields PA; Milner R; Wainwright L; De Miguel MP; Donovan PJ; Herzog RW; Nichols TC; Biegel JA; Razavi M; Dake M; Huff D; Flake AW; Couto L; Kay MA; High KA Mol Ther; 2001 Dec; 4(6):586-92. PubMed ID: 11735343 [TBL] [Abstract][Full Text] [Related]
20. Induction of immunity to antigens expressed by recombinant adeno-associated virus depends on the route of administration. Brockstedt DG; Podsakoff GM; Fong L; Kurtzman G; Mueller-Ruchholtz W; Engleman EG Clin Immunol; 1999 Jul; 92(1):67-75. PubMed ID: 10413654 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]